Graz, Austria

Johannes Kerbl

This inventor holds 1 USPTO granted patent. Top assignee: Knoll Aktiengesellschaft. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Johannes Kerbl in Pharmaceutical Emulsions

Introduction

Johannes Kerbl is a notable inventor based in Graz, Austria. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable emulsions. His work focuses on enhancing the delivery of active substances in medical applications.

Latest Patents

Johannes Kerbl holds a patent for a stable emulsion suitable for pharmaceutical administration. This invention describes a stable active substance emulsion of the oil-in-water type, utilizing a phospholipid as an emulsifier. The active substance, which is hydrophobic and oil-soluble, is dissolved in the lipid phase and possesses one or more basic groups with a pKa of at least 7.5. The aqueous phase is maintained at an acidic pH, and the disperse phase achieves a positive zeta potential of at least +15 mV, preferably +30 mV, after dilution to a fat content of 0.08% by weight.

Career Highlights

Johannes Kerbl is associated with Knoll Aktiengesellschaft, a company known for its advancements in pharmaceutical products. His innovative approach to emulsions has the potential to improve drug delivery systems significantly.

Collaborations

Throughout his career, Johannes has collaborated with notable professionals in the field, including Kurt Lanthaler and Stanley Stewart Davis. These partnerships have contributed to the development and refinement of his inventions.

Conclusion

Johannes Kerbl's work in creating stable emulsions for pharmaceutical use showcases his innovative spirit and dedication to improving medical formulations. His contributions are valuable to the ongoing advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…